Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nothing to be resolved. All endpoints met!
Nothing needs shown, to anyone! AVXL has the goods and only needs to show it to the FDA. TGA EU regulators!
An irrational take down over the last 10 years is what shorts have provoked!
Any problems with data from ANAVEX are a figment from your imagination. The P3 TLR is stellar! Nothing else required!
To you maybe the fact that “rectification” means major adjust to rectum, might mean more!
The entire trading paradigm is going to change, because there are a bunch of things that have been ignored about ANAVEX. The WS bunch have really beat the price down under $10. This beat down has been prevailing for about 10 years. A couple of things happened that everyone will recognize:
1. A 2-73 P2b/3 AD Clinical Trial TLR reported that ALL ENDPOINTS MET.
2. H.C. Wainwright analyst put the Price Target for AVXL at $50 ( up from $42). Selvaru (sp?) has followed over 5 yr.
3. Short Interest is at a record Over 20% of float!
Some rectification has come due?
It should be easy for Dr M to get TGA to expand the SAS program to all ALZHEIMER’S patients using the existing P3 AD trial results! So I guess the real play is now to bet on expansion of QANTAS airlines, if the FDA fails to approve ANAVEX A 2-73? I would expect a great many ALZ patients in the US will prefer the much better outcome from taking A 2-73, improvement in cognition!
Yes, the more deaths of ALZHEIMERS patients the merrier? 4 patients have already passed away with lec..mab or BAN2401 or lem… . I haven’t heard why the FDA didn’t look into the BRAIN BLEEDING & BRAIN SWELLING more before they rushed to approval? Questionable decision.
Makes ANAVEX the only choice for ALZHEIMER’S patients that want to live.
Not so. The biggest contribution of ANAVEX will be to humanity. It will finally take old age away from ALZHEIMERS and a many other diseases. Also RETTS girls will get a better life!
Nice post steady!
Maybe until the ROW approves A 2-73. And we get 1M+ super responders!
Good News is because only 4 people were killed in that trial?
The real question is: does it improve cognition? The answer is no. No improvement. = No efficacy!
Should not have been approved on basis of 4 dead!
Looks like the BP S(h)ORTS are still going at ANAVEXs throat, with at stronghold at 10. That will look like a back off, because it is not sitting in the 7s. Give this some time and we will find the 7s again for ANAVEX. The real gut punch will be the MEDICARE ante up to pay for the BB&BS infusions and MRIs. After that watch the BP S(h)HORTS they get their legs and ANAVEX gets pressured possibly back to 6s.
Only remote possibility is we see some regulatory moment in ANAVEXs direction.
Has Medicare said that the FEDs are going to ante up for these BB&BS infusion shots?
Decerning the truth is easier if you first identify the fudster involved and forget anything he says. ANAVEX is truth.
It means what you think and say about ANAVEx are important to you but are not necessarily important. That is not the case with what Dr M says. He has all the responsibility and authority to speak what is necessary, required, and true. He is extremely well trained. I feel it is important not to make any assumptions beyond what he commented.
Frankly you are only qualified to hear what Dr M has said. I standby what Dr M has said. Nothing needs to change. He has no more data he is now required to deliver to the public.
Dr M only needs to proceed with NDA and discuss the results with the TGA FDA & other regulators. After this he is required to deliver the hoped for positive approval decisions of the regulators.
The cabal is aligned anti ANAVEX due to status quo maintenance for self preservation targets.
Really they show that the status quo cabal is pervasive and huge!
At 3:30 today, the Fidelity mobile app started refusing to produce any quotes for AVXL. That denies retail investors the ability to trade shares of AVXL using FIDELITY MONILE!
Raja, looking at the wrong end of the horse? Have the cart hooked up backwards? A lower stock price is the output of the status quo cabals effort! Certainly not the input!
It even looks that Fidelity turns off quotes of ANAVEX (AVXL) Stock when above $10 today! That inhibits trading in AVXL when the price is above $10!
The status quo cabal is truely collusion on a grand scale, never tolerated! Will it continue?
It don’t make no difference. Whenever Missling speaks the status quo cabal will make fodder of whatever he says no matter how well put. They just need to process. Once out eventually it will sink in. The status quo cabal is so large that their suppression of ANAVEX including stock price will prevail until revenue starts!
Give it some time before judgement. The status quo cabal is huge! Enemies of ANAVEX are coming out of the woodwork to step in front of its progress. There are efforts to keep ANAVEX suppressed on all fronts!
The FDA is actually considering the approval of another anti-A-Beta drug from BIIB this Friday, Jan 6, 2023!
Why should the company’s product be considered for approval when there is not a whiff of evidence of improved cognition?
Actually it deteriorates health of patients producing BB&BS and in 3 cases in Clinical Trial: DEATH! And it requires unusual methods of infusion along with unusual methods of monitoring - 6 BRAIN MRIs per year. At incredible cost. All to no avail?
Consider ANAVEXs BLARCAMESINE ( A 2-73 )orally consumed pill once daily and no monitoring MRIs. Relatively inexpensive. Effective. Produces improvements in cognition!
This is just what the FDA should be addressing on Jan 6, 2023, Friday!
It’s down 50% over the last year, so ANY down move is a slide!
No actually the shorty cabal is much broader than that. There are ingrained organizations that want ALZHEIMERS to retain its gorilla sized disease stature for the purpose of status quo maintenance. For example the ALZHEIMERS ASSOCIATIONs rep at ATAD 2022 omitted any mention of ANAVEX in her company meeting report? Or does she have ALZHEIMERS??
Looks like collusive short gang wants to manipulate the price of AVXL, and keep it below $10.
I’m inclined to agree with you. The FDA has a lot of egg on face from the ADUHELM debacle, and approving BIIBs new drug ( BAN2401 or lec…mab ) would only add more face egg.
Actually Dr M said “Everyone benefits with A 2-73.”
Results mentioned do support the TLR STATEMENTS! The 50 mg results will be like an atomic bomb that annihilates the Fudster landscape! Q
It’s just yet another criminally manipulated stock price day for ANAVEX. This counts 30 days of total criminal manipulation of ANAVEX STOCK since the amazing TLR results were announced on DEC 1, 2022.
That’s pure FUDSTER BS!
Much preferred is Dr M!
FUDSTERS are confused. The trial results are “all endpoints met”! It is definite, a P3,
Your in fantasy land! All endpoints easily met. Further details will only be delivered to regulators and published later. There is no requirement to divulge now.
Just more proof there is!
All endpoints met in 509 patient PHASE 3 EARLY ALZHEIMERS CLINICAL TRIAL for ANAVEX A 2-73. Short interest is at an historical high 20% of the 78M share float.
Large criminal orchestration of shorts to produce this stock price takedown in the face of incredibly positive results. It will have to be looked into by AG, DOJ, and SEC!